Commonwealth Equity Services’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $370K | Buy |
32,954
+928
| +3% | +$10.4K | ﹤0.01% | 3413 |
|
|
2025
Q1 | $146K | Buy |
32,026
+74
| +0.2% | +$337 | ﹤0.01% | 3925 |
|
|
2024
Q4 | $180K | Buy |
31,952
+4,785
| +18% | +$27K | ﹤0.01% | 3800 |
|
|
2024
Q3 | $131K | Sell |
27,167
-791
| -3% | -$3.81K | ﹤0.01% | 3817 |
|
|
2024
Q2 | $136K | Buy |
27,958
+357
| +1% | +$1.74K | ﹤0.01% | 3757 |
|
|
2024
Q1 | $367K | Buy |
27,601
+15,116
| +121% | +$201K | ﹤0.01% | 3088 |
|
|
2023
Q4 | $174K | Buy |
+12,485
| New | +$174K | ﹤0.01% | 3561 |
|